Tongji Medical College, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Department of Ophthalmology, Huazhong University of Science & Technology, Wuhan, China.
Tongji Medical College, Union Hospital, Department of Ophthalmology, Huazhong University of Science & Technology, Wuhan, China.
JAMA Ophthalmol. 2020 Oct 1;138(10):1079-1086. doi: 10.1001/jamaophthalmol.2020.3690.
Ocular manifestations and outcomes in children with confirmed coronavirus disease 2019 (COVID-19), relevant affecting factors, and differences in ocular disease between children and adults have yet to be fully understood.
To investigate ocular manifestations and clinical characteristics of children with laboratory-confirmed COVID-19.
DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study was conducted at Wuhan Children's Hospital in Wuhan, China. Children with COVID-19 confirmed by severe acute respiratory syndrome coronavirus disease 2 nucleic acid tests of upper respiratory tract specimens between January 26 and March 18, 2020, were included.
Onset clinical symptoms and duration, ocular symptoms, and needs for medication.
A total of 216 pediatric patients were included, among whom 134 (62%) were boys, with a median (interquartile range) age of 7.25 (2.6-11.6) years. Based on the exposure history, 193 children (89.4%) had a confirmed (173 [80.1%]) or suspected (20 [9.3%]) family member with COVID-19 infection. The most common symptoms among symptomatic children were fever (81 [37.5%]) and cough (79 [36.6%]). Of 216 children, 93 (43.1%) had no systemic or respiratory symptoms. All children with mild (101 [46.8%]) or moderate (115 [53.2%]) symptoms recovered without reported death. Forty-nine children (22.7%) showed various ocular manifestations, of which 9 had ocular complaints being the initial manifestations of COVID-19. The common ocular manifestations were conjunctival discharge (27 [55.1%]), eye rubbing (19 [38.8%]), and conjunctival congestion (5 [10.2%]). Children with systemic symptoms (29.3% vs 14.0%; difference, 15.3%; 95% CI, 9.8%-20.7%; P = .008) or with cough (31.6% vs 17.5%; difference, 14.1%; 95% CI, 8.0%-20.3%; P = .02) were more likely to develop ocular symptoms. Ocular symptoms were typically mild, and children recovered or improved.
In this cross-sectional study, children hospitalized with COVID-19 in Wuhan, China, presented with a series of onset symptoms including fever, cough, and ocular manifestations, such as conjunctival discharge, eye rubbing, and conjunctival congestion. Patients' systemic clinical symptoms or cough were associated with ocular symptoms. Ocular symptoms recovered or improved eventually.
儿童感染新型冠状病毒(COVID-19)后的眼部表现和结局、相关影响因素以及儿童与成人眼部疾病的差异尚未完全明确。
研究经实验室确诊的 COVID-19 患儿的眼部表现和临床特征。
设计、地点和参与者:这是一项在中国武汉儿童医院进行的横断面研究。纳入 2020 年 1 月 26 日至 3 月 18 日期间,经严重急性呼吸综合征冠状病毒 2 型核酸检测阳性的上呼吸道标本确诊为 COVID-19 的患儿。
发病时的临床症状和持续时间、眼部症状以及药物治疗需求。
共纳入 216 例儿科患者,其中 134 例(62%)为男性,中位(四分位距)年龄为 7.25(2.611.6)岁。根据接触史,193 例(89.4%)患儿有确诊(173 例[80.1%])或疑似(20 例[9.3%])COVID-19 感染的家庭成员。有症状患儿最常见的症状是发热(81 例[37.5%])和咳嗽(79 例[36.6%])。216 例患儿中,93 例(43.1%)无全身或呼吸系统症状。所有轻症(101 例[46.8%])或中症(115 例[53.2%])患儿均康复,无死亡报告。49 例(22.7%)患儿出现各种眼部表现,其中 9 例患儿的眼部不适是 COVID-19 的首发症状。常见的眼部表现有结膜分泌物(27 例[55.1%])、眼摩擦(19 例[38.8%])和结膜充血(5 例[10.2%])。有全身症状(29.3%比 14.0%;差值,15.3%;95%CI,9.8%20.7%;P=0.008)或咳嗽(31.6%比 17.5%;差值,14.1%;95%CI,8.0%~20.3%;P=0.02)的患儿更有可能出现眼部症状。眼部症状通常较轻,患儿恢复或改善。
在这项横断面研究中,中国武汉因 COVID-19 住院的患儿出现了一系列首发症状,包括发热、咳嗽和眼部表现,如结膜分泌物、眼摩擦和结膜充血。患儿的全身临床症状或咳嗽与眼部症状相关。眼部症状最终恢复或改善。